Literature DB >> 19952933

Paget disease of the vulva: a histologic study of 56 cases correlating pathologic features and disease course.

Ruthy Shaco-Levy1, Sarah M Bean, Robin T Vollmer, John A Papalas, Rex C Bentley, Maria Angelica Selim, Stanley J Robboy.   

Abstract

The Duke experience with 56 vulvar Paget disease patients was analyzed emphasizing pathologic features and controversial issues. Nearly all patients were Caucasian, and their mean age was 69 years. The average length of follow-up was 5.6 years. For each case, the following histologic features were evaluated and their association with disease course was examined: pseudo-invasion, adnexal involvement, signet-ring cells, cytologic atypia, glands formation, epidermal acantholysis, parakeratosis, hyperkeratosis, and chronic inflammation. The recurrence rate after surgical management was 32%, with epidermal acantholysis being the only statistically significant risk factor. Stromal invasion occurred in 10 patients (18%), and was not a statistically significant adverse prognostic indicator, although the single patient who died of the disease had the deepest stromal invasion. Recurrence was more common after resections with positive surgical margins, but this correlation was not statistically significant. Intraoperative frozen section analysis of the margins did not reduce recurrence rate, nor was it useful in attaining permanent free margins. The Paget cells were consistently reactive with cytokeratin-7 and carcinoembryonic antigen and unreactive with S-100 protein, HMB-45, and Mart-1. In addition, the tumor cells were usually positive for mucin stains. This profile helps distinguish vulvar Paget disease from its mimics, Pagetoid squamous cell carcinoma and malignant melanoma.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19952933     DOI: 10.1097/PGP.0b013e3181b1cc5e

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN: 0277-1691            Impact factor:   2.762


  9 in total

Review 1.  Effects of imiquimod on vulvar Paget's disease: a systematic review of literature.

Authors:  Hiroko Machida; Aida Moeini; Lynda D Roman; Koji Matsuo
Journal:  Gynecol Oncol       Date:  2015-07-17       Impact factor: 5.482

2.  Clinical treatment of vulvar Paget's disease: a case report.

Authors:  Cristina Anton; Arthur Vicentini da Costa Luiz; Filomena Marino Carvalho; Edmund Chada Baracat; Jesus Paula Carvalho
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

3.  Paget's Disease of the Vulva in Premenopausal Woman Treated with Only Surgery: A Case Report.

Authors:  Hamid Asmouki; Rachid Oumouloud; Abderrahim Aboulfalah; Abderraouf Soummani; Abdelouahed Marrat
Journal:  Case Rep Oncol Med       Date:  2012-09-16

4.  Interventions for the treatment of Paget's disease of the vulva.

Authors:  Katharine A Edey; Ernest Allan; John B Murdoch; Susan Cooper; Andrew Bryant
Journal:  Cochrane Database Syst Rev       Date:  2019-06-05

5.  Apocrine Carcinoma of the Axilla Associated with Extramammary Paget's Disease: A Case Report and Review of the Literature.

Authors:  Hye Ra Jung; Sun Young Kwon; Daegu Son
Journal:  J Pathol Transl Med       Date:  2015-09-17

6.  GATA3 is a sensitive marker for primary genital extramammary paget disease: an immunohistochemical study of 72 cases with comparison to gross cystic disease fluid protein 15.

Authors:  Ming Zhao; Lixin Zhou; Li Sun; Yan Song; Yunquan Guo; Xun Zhang; Feng Zhao; Peng Wang; Junqiu Yue; Dongfeng Niu; Zhongwu Li; Xiaozheng Huang; Qiang Kang; Lin Jia; Jinping Lai; Dengfeng Cao
Journal:  Diagn Pathol       Date:  2017-07-10       Impact factor: 2.644

7.  The Paget Trial: A Multicenter, Observational Cohort Intervention Study for the Clinical Efficacy, Safety, and Immunological Response of Topical 5% Imiquimod Cream for Vulvar Paget Disease.

Authors:  Michelle van der Linden; Kim Meeuwis; Colette van Hees; Eleonora van Dorst; Johan Bulten; Tjalling Bosse; Joanna IntHout; Dorry Boll; Brigitte Slangen; Manon van Seters; Marc van Beurden; Mariëtte van Poelgeest; Joanne de Hullu
Journal:  JMIR Res Protoc       Date:  2017-09-06

8.  Japan Society of Gynecologic Oncology guidelines 2015 for the treatment of vulvar cancer and vaginal cancer.

Authors:  Toshiaki Saito; Tsutomu Tabata; Hitoshi Ikushima; Hiroyuki Yanai; Hironori Tashiro; Hitoshi Niikura; Takeo Minaguchi; Toshinari Muramatsu; Tsukasa Baba; Wataru Yamagami; Kazuya Ariyoshi; Kimio Ushijima; Mikio Mikami; Satoru Nagase; Masanori Kaneuchi; Nobuo Yaegashi; Yasuhiro Udagawa; Hidetaka Katabuchi
Journal:  Int J Clin Oncol       Date:  2017-11-20       Impact factor: 3.402

9.  Vulvar malignancies: an interdisciplinary perspective.

Authors:  Christoph Wohlmuth; Iris Wohlmuth-Wieser
Journal:  J Dtsch Dermatol Ges       Date:  2019-12-12       Impact factor: 5.584

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.